These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2652595)

  • 1. Transplant outcome with donor specific buffy-coat and lymphocyte-transfused patients.
    Okazaki H; Takahashi H; Jimbo M; Iguro T; Satoh T; Ishizak M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1832-3. PubMed ID: 2652595
    [No Abstract]   [Full Text] [Related]  

  • 2. Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion.
    Okazaki H; Takahashi H; Miura K; Ishizaki M; Taguchi Y
    Transplantation; 1984 May; 37(5):523-5. PubMed ID: 6233767
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine.
    Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized study of buffy coat transfusions in cadaveric renal transplantation.
    Norman DJ; Fletcher L; Barry J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1967-70. PubMed ID: 3547901
    [No Abstract]   [Full Text] [Related]  

  • 6. Transplant outcome of desensitized recipients after donor-specific transfusion.
    Okazaki H; Takahashi H; Oguma S; Jimbo M; Ishizaki M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):750-2. PubMed ID: 3274863
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience of blood transfusion in renal transplantation.
    Frisk B; Berglin E; Blohmé I; Persson H; Sandberg L; Wedel N; Brynger H
    Scand J Urol Nephrol Suppl; 1984; 88():1-69. PubMed ID: 6399773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor specific transfusions: a five-year experience with alternative protocols.
    Norman DJ; Henell K; Fletcher L; Barry J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2252-4. PubMed ID: 3274504
    [No Abstract]   [Full Text] [Related]  

  • 9. Three year experience of donor specific transfusion and concomitant cyclosporine A.
    Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of kidney graft survival in dog and man by pre-operative transfusion to the donor.
    Jeekel J; Van der Linden CJ; Vegt PA; Buurman WA; Harder F; Persijn G
    Proc Eur Dial Transplant Assoc; 1980; 17():457-61. PubMed ID: 7017690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry.
    Sonoda T; Ishibashi M
    Clin Transpl; 1987; ():257-60. PubMed ID: 2978999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kidney transplantation and blood transfusion--with special reference to preoperative blood transfusion].
    Taguchi Y; Okazaki H
    Masui; 1985 Oct; 34(10):1391-409. PubMed ID: 3912522
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of transfusions on renal allograft survival in the cyclosporine era: a single center report.
    Egidi MF; Scott DH; Corry RJ
    Clin Transplant; 1993 Jun; 7(3):240-4. PubMed ID: 10148843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of DST alone and DST with intermittent coverage by cyclophosphamide.
    Kasai I; Kumano K; Iwamura M; Yoshida K; Mashimo S; Endo T; Sakai T; Koshiba K; Iitaka K; Uchida H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1837-8. PubMed ID: 2652598
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors.
    Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.